Editas Medicine (EDIT) Current Assets (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Current Assets data on file, last reported at $163.9 million in Q4 2025.

• Current Assets for Q4 2025 came in at $163.9 million, down 43.35% year-over-year; the trailing twelve-month figure through Dec 2025 was $163.9 million (down 43.35% YoY), and the FY2025 annual result was $163.9 million, down 43.35% from the prior year.
• Current Assets retreated to $163.9 million in Q4 2025 per EDIT's latest filing, from $176.9 million in the prior quarter.
• Over five years, Current Assets peaked at $632.3 million in Q1 2021 and troughed at $163.9 million in Q4 2025.
• A 5-year average of $371.5 million and a median of $348.8 million in 2022 frame the typical range for Current Assets.
• The sharpest annual moves came in 2021 and 2025: Current Assets jumped 48.74% in 2021, then plunged 43.35% in 2025.
• A 5-year view of Current Assets shows it stood at $507.3 million in 2021, then decreased by 29.68% to $356.8 million in 2022, then retreated by 4.46% to $340.8 million in 2023, then dropped by 15.11% to $289.3 million in 2024, then sank by 43.35% to $163.9 million in 2025.
• Business Quant data shows EDIT's Current Assets at $163.9 million in Q4 2025, $176.9 million in Q3 2025, and $182.8 million in Q2 2025.